Key clinical point: Chronic lymphocytic leukemia and breast cancer microRNAs show diagnostic and prognostic potential.
Major finding: Studied microRNA expression in breast cancer and chronic lymphocytic leukemia patients was significantly higher than in healthy controls (P less than .001).
Study details: A molecular analysis of blood from 15 chronic lymphocytic leukemia patients and tissue samples from 15 breast cancer patients.
Disclosures: The authors reported that they had no competing interests.
Raeisi F et al. Mol Ther Oncolytics. 2020;16:230-7.